Literature DB >> 11380802

Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a.

J Bukh1, C L Apgar, S Govindarajan, S U Emerson, R H Purcell.   

Abstract

The chimpanzee is the only recognized animal model for the study of hepatitis C virus (HCV). However, recently it was reported that rhesus monkeys were susceptible to HCV and developed hepatitis during infection. In the present study, we inoculated two rhesus monkeys each with HCV strain H77 (genotype 1a), strain HC-J6 (genotype 2a) or strain S52 (genotype 3a). Weekly serum samples were tested for liver enzyme values, HCV antibodies and HCV RNA. We did not find evidence of HCV infection in any of the monkeys during 24 weeks of follow-up. Our study demonstrates that rhesus monkeys are not readily infected with HCV and apparently do not represent a useful animal model for the study of HCV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380802     DOI: 10.1046/j.1365-2893.2001.00284.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.

Authors:  Margaret A Scull; Chao Shi; Ype P de Jong; Gisa Gerold; Moritz Ries; Markus von Schaewen; Bridget M Donovan; Rachael N Labitt; Joshua A Horwitz; Jenna M Gaska; Gabriela Hrebikova; Jing W Xiao; Brenna Flatley; Canny Fung; Luis Chiriboga; Christopher M Walker; David T Evans; Charles M Rice; Alexander Ploss
Journal:  Hepatology       Date:  2015-04-15       Impact factor: 17.425

2.  Hepatitis C virus's next top models?

Authors:  David Paul; Ralf Bartenschlager
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

Review 3.  Current progress in development of hepatitis C virus vaccines.

Authors:  T Jake Liang
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.

Authors:  Jiaren Sun; Batbayar Tumurbaatar; Junhui Jia; Hong Diao; Francis Bodola; Stanley M Lemon; Wendell Tang; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino; Teh-Sheng Chan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress.

Authors:  Xiao-Liang Zhang; Wei Pang; Xin-Tian Hu; Jia-Li Li; Yong-Gang Yao; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-11-18

6.  Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.

Authors:  Marion Sourisseau; Orit Goldman; Wenqian He; Jennifer L Gori; Hans-Peter Kiem; Valerie Gouon-Evans; Matthew J Evans
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

Review 7.  The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae.

Authors:  Jack T Stapleton; Steven Foung; A Scott Muerhoff; Jens Bukh; Peter Simmonds
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

8.  Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.

Authors:  Markus von Schaewen; Marcus Dorner; Kathrin Hueging; Lander Foquet; Sherif Gerges; Gabriela Hrebikova; Brigitte Heller; Julia Bitzegeio; Juliane Doerrbecker; Joshua A Horwitz; Gisa Gerold; Sebastian Suerbaum; Charles M Rice; Philip Meuleman; Thomas Pietschmann; Alexander Ploss
Journal:  mBio       Date:  2016-11-08       Impact factor: 7.867

9.  Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus.

Authors:  Jenna M Gaska; Metodi Balev; Qiang Ding; Brigitte Heller; Alexander Ploss
Journal:  Elife       Date:  2019-05-10       Impact factor: 8.140

10.  Nonprimate hepaciviruses in domestic horses, United kingdom.

Authors:  Sinéad Lyons; Amit Kapoor; Colin Sharp; Bradley S Schneider; Nathan D Wolfe; Geoff Culshaw; Brendan Corcoran; Bruce C McGorum; Peter Simmonds
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.